NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmerican Campus Communities ( ACC) was downgraded to hold at TheStreet Ratings. Accenture ( ACN) was upgraded at Robert Baird to outperform from neutral. $86 price target. Stock has trailed, creating a buying opportunity, Robert Baird said. Bruker ( BRKR) was upgraded at Bank of America/Merrill Lynch to buy. $26 price target. Company trades at a 40% discount to its peers, but can expand margins, BofA/Merrill said. Cisco ( CSCO) was upgraded at J.P. Morgan to neutral from underweight. $26 price target. Enterprise networking trends improving, J.P. Morgan said. Concho ( CXO) was downgraded at UBS to neutral from buy and given a $103 price target. Valuation is full, and there is upside risk to capex, UBS said. Deere ( DE) was downgraded at UBS to sell from neutral and given a $72 price target. Lower corn prices will pressure demand for Ag equipment, UBS said. Devry ( DV) was downgraded at Compass Point to neutral from buy. $28 price target. Expect continued deterioration and the university and medical internation program, Compass Point said. IHS ( IHS) was upgraded at Deutsche Bank to buy from hold. $125 price target. Improving economy could lead to accelerating sales growth, Deutsche Bank said.
Mistras Group ( MG) was downgraded to hold at TheStreet Ratings. Onyx Pharmaceuticals ( ONXX) was downgraded at BMO Capital to market perform from outperform. $143 price target. Company is seeing slower sales growth, BMO Capital said. Orbitz ( OWW) was downgraded at Lazard Capital Markets to neutral from buy. Valuation call, as the stock has made a big run, Lazard Capital Markets said. Suntrust ( STI) was downgraded at Argus Research to hold from buy. Valuation call, as the stock is up 60% since last June, Argus said.
St. Jude ( STJ) was upgraded at Wells Fargo to outperform from market perform. CardioMEMS will likely receive U.S. approval and the stock is the cheapest in the industry, Wells said. Sun Edison ( SUNE) was downgraded at Ardour to hold from buy. Valuation call, based on an $8 price target, Ardour said.